Sort   by:  
 Page size 
ProteomicsCardioprotection by selective SGLT2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?
Major clinical trials with sodium glucose co-transporter-2 inhibitors (SGLT-2i) exhibit protective effects against heart failure events, whereas inconsistencies regarding the cardiovascular death outcomes are observed. Therefore, we aimed to compare the selective SGLT-2i empagliflozin (EMPA), dapagl...
ORGANISM(S): Mus Musculus (ncbitaxon:10090) 
2021-12-17 | MSV000088582 | MassIVE
GenomicsThe effects of SGLT-2 inhibitors canagliflozin on hepatic transcription
The effects of SGLT-2 inhibitors canagliflozin on hepatic transcription
PRJNA471915 | ENA
GenomicsThe effects of SGLT-2 inhibitors canagliflozin on hepatic transcription
The effects of SGLT-2 inhibitors canagliflozin on hepatic transcription
PRJNA625454 | ENA
TranscriptomicsThe effects of SGLT-2 inhibitors canagliflozin on hepatic transcription
We assessed the change in hepatic transciptional pattern after treatment with SGLT-2 inhibitors canagliflozin in a mice model of diet-induced obesity.
ORGANISM(S): Mus musculus 
2021-05-13 | GSE114614 | GEO
TranscriptomicsThe effects of SGLT-2 inhibitors canagliflozin on hepatic transcription
We assessed the change in hepatic transciptional pattern after treatment with SGLT-2 inhibitors canagliflozin in a mice model of diet-induced obesity. Pharmacologic inhibition of the renal sodium/glucose cotransporter-2 induces glycosuria and reduces glycemia. Given that SGLT2 inhibitors (SGLT2i) re...
ORGANISM(S): Mus musculus 
2020-04-16 | GSE148702 | GEO
UnknownNew Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors.
Not available
S-EPMC5871636 | biostudies-literature
UnknownLiraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis.
Not available
S-EPMC5306116 | biostudies-literature
UnknownRenoprotective Effect of Thai Patients with Type 2 Diabetes Mellitus Treated with SGLT-2 Inhibitors versus DPP-4 Inhibitors: A Real-World Observational Study.
Not available
S-EPMC10202602 | biostudies-literature
UnknownEvolving channeling in prescribing SGLT-2 inhibitors as first-line treatment for type 2 diabetes.
Not available
S-EPMC8989653 | biostudies-literature
UnknownDoes Gender Influence the Cardiovascular Benefits Observed with Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors? A Meta-Regression Analysis.
Not available
S-EPMC5446808 | biostudies-literature
Sort   by:  
 Page size